Targeted NAD+ repletion via biomimetic nanoparticle enables simultaneous management of intimal hyperplasia and accelerated re-endothelialization: A proof-of-concept study toward next-generation of endothelium-protective, anti-restenotic therapy
Yin Li(Northwestern University), Bowen Wang(Northwestern University), Shaoqin Gong(University of Wisconsin–Madison), Nicholas Hoyt(George Washington University), Lian‐Wang Guo(University of Virginia), Zhanpeng Zhang(Wisconsin Institutes for Discovery), Eric William Kent(University of Virginia), Zain Husain Islam(University of Virginia), Kaijie Zhang(Northwestern University), Yao Tong(University of Wisconsin–Madison), Sophia Stanisic(University of Virginia), William Aaron Marcum(University of Virginia), Rohan Kanchetty(University of Virginia), Zoe Tetz(University of Virginia), Yitao Huang(University of Virginia), Ruosen Xie(University of Wisconsin–Madison), Campbell Johnston(University of Virginia), Jacobus W. A. Burger(Radboud University Nijmegen)
Cited by 4
Related Papers
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
|The Lancet. Gastroenterology & hepatology|2019|326
NAD(H)-loaded nanoparticles for efficient sepsis therapy via modulating immune and vascular homeostasis
|Nature Nanotechnology|2022|150
Long-Term Results of Tumor Necrosis Factor α– and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas
|Journal of Clinical Oncology|2011|100
Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections
|Nature Nanotechnology|2024|89